Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DAWN
- 31 Aug 2018 Biomarkers information updated
- 14 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Jul 2008 New trial record.